MSB 1.09% 92.5¢ mesoblast limited

AHA conference details

  1. 1,363 Posts.
    lightbulb Created with Sketch. 116

    10.30 am Melbourne time.  


    LBS.06 - Late Breaking Science in Coronary Revascularization

    When: Sunday, November 11, 2018, 5:30 p.m.– 6:45 p.m.
    Where: Main Event II (s100)

    • REGROUP
      Endoscopic Vein Harvest for Coronary Bypass Surgery in a Randomized Multicenter Trial With Long-Term Follow-up 
       
    • FREEDOM Follow-On Study
      Long-term Survival following Multivessel Revascularization in Patients with Diabetes: the FREEDOM Follow-On Study 
       
    • TiCAB
      A Randomized, Double-blind Study Of Ticagrelor Versus Aspirin In Patients Undergoing Coronary Bypass Surgery
       
    • ISAR TEST 4
      Ten-Year Clinical Outcomes After Coronary Drug-Eluting Stents with Biodegradable or Permanent Polymer Coating: Results from the Randomized ISAR-TEST 4 Trial 
       
    • Intramyocardial Injection of Mesenchymal Precursor Cells in Left Ventricular Assist Device Recipients: Impact on Myocardial Recovery and Morbidity
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.5¢
Change
0.010(1.09%)
Mkt cap ! $1.056B
Open High Low Value Volume
90.5¢ 94.0¢ 89.5¢ $4.970M 5.436M

Buyers (Bids)

No. Vol. Price($)
1 18877 92.0¢
 

Sellers (Offers)

Price($) Vol. No.
92.5¢ 6795 1
View Market Depth
Last trade - 16.10pm 08/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.